ITMCTR2024000221尚未招募1 期
Effect of Danlou Tablets with good compliance to medical advice on the risk of short-term adverse cardiovascular events after PCI in patients with coronary heart disease
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 80（—）
- 性别
- All
入选标准
- •1: Patients who were hospitalized for coronary heart disease and received PCI during hospitalization, or were hospitalized for other diseases but received PCI during hospitalization due to the appearance or aggravation of coronary heart disease symptoms, or were outpatients who received PCI for coronary heart disease in other hospitals within the past 2 weeks. Patients who met one of the above criteria and were diagnosed with phlegm and blood stasis syndrome by TCM met the inclusion criteria.
排除标准
- •1) Aged over 80 years old 2) Combined with malignant tumors and other diseases that seriously affect survival expectations 3) Children, minors and pregnant women
研究者
相似试验
尚未招募
4 期
Effects of Dan-Lou Tablet for Coronary Heart Disease Stable Angina Pectoris with Intermingled Phlegm and Blood Stasis Pattern: A Randomized, Double-blinded, Parallel Placebo controlled TrialCoronary heart disease stable angina pectorisITMCTR1900002839Guang'anmen Hospital,Chinese Academy of Traditiona Chinese medicine
尚未招募
4 期
Study for the effect of Danlou tablet on gut microbiota of CHD patients and its metabolomicsITMCTR1900002563Traditional Chinese Medicine Hospital of Tailai County, Qiqihar City, Heilongjiang Province
Unknown
4 期
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to RevascularizationCoronary Artery Disease(CAD)NCT03072082Jun Li440
已完成
不适用
The effect and safety of single tablet of fixed dose mitiglinide and voglibose when changed from DPP-4 inhibitorType 2 diabetes mellitusJPRN-UMIN000011148Department of Internal Medicine, School of Medicine, Keio University30
已完成
4 期
A clinical trial to study the effects of two doses of a drug Duloxetine in peripheral neuropathic pain in patients undergoing treatment with Taxane (anticancer drug).CTRI/2017/02/007886Mysore Medical College and Research Institute44